Internal Medicine, Endocrinology, Diabetes, & Metabolism · Pearland, TX
NPI
1770679573
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
10970 Shadow Creek Pkwy, Suite 270
Pearland, TX, 77584
Phone (866) 693-4223
Groups this clinician bills Medicare through
Medicare paid, 2024
$71K
2,413 services
Medicare patients, 2024
226
Average age 73
Drug cost, 2024
$5.3M
8,994 prescriptions
Company payments, 2025
$14K
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Timothy Daniel was code 99214 (office e&m - established), 509 times for 216 patients. In total Timothy Daniel billed 2,413 services in 27 codes, and Medicare paid $71K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-11-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 509 | 216 | $90.46 | $46K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 489 | 213 | $12.41 | $6,068 |
| 83036 Blood Count | Office | 413 | 204 | $9.48 | $3,915 |
| 82962 Clinical Chemistry | Office | 292 | 184 | $3.19 | $932 |
| 95251 Test - Miscellaneous | Office | 187 | 89 | $25.92 | $4,848 |
| 82947 Clinical Chemistry | Office | 89 | 75 | $3.85 | $343 |
| 84443 Clinical Chemistry | Office | 49 | 49 | $16.46 | $807 |
| 85025 Blood Count | Office | 49 | 49 | $7.61 | $373 |
| 80053 Clinical Chemistry | Office | 46 | 46 | $10.35 | $476 |
| 84439 Clinical Chemistry | Office | 46 | 46 | $8.65 | $398 |
| 80061 Clinical Chemistry | Office | 45 | 45 | $13.12 | $590 |
| 82570 Clinical Chemistry | Office | 43 | 42 | $5.08 | $218 |
| 82043 Clinical Chemistry | Office | 43 | 42 | $5.66 | $243 |
| G0108 Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 37 | 34 | $41.42 | $1,532 |
| 99204 Office E&M - New | Office | 21 | 20 | $125.51 | $2,636 |
By year: 2022 $88K for 2,523 services; 2023 $67K for 1,838 services; 2024 $71K for 2,413 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 413 | 204 | $9.48 | $3,915 |
| 82962 Clinical Chemistry | 292 | 184 | $3.19 | $932 |
| 82947 Clinical Chemistry | 89 | 75 | $3.85 | $343 |
| 85025 Blood Count | 49 | 49 | $7.61 | $373 |
| 84443 Clinical Chemistry | 49 | 49 | $16.46 | $807 |
| 80053 Clinical Chemistry | 46 | 46 | $10.35 | $476 |
| 84439 Clinical Chemistry | 46 | 46 | $8.65 | $398 |
| 80061 Clinical Chemistry | 45 | 45 | $13.12 | $590 |
| 82043 Clinical Chemistry | 43 | 42 | $5.66 | $243 |
| 82570 Clinical Chemistry | 43 | 42 | $5.08 | $218 |
Medicare prescription drug claims, 2024
In 2024, the drug Timothy Daniel prescribed most often to Medicare patients was Ozempic (Semaglutide), with 1,014 prescriptions and refills. In total Timothy Daniel wrote 8,994 Medicare prescriptions that cost $5.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 1,014 | 1,438 | 231 | $1.3M |
| Metformin Hcl Er Metformin Hcl | 643 | 1,780 | 229 | $7,942 |
| Mounjaro Tirzepatide | 439 | 537 | 85 | $545K |
| Jardiance Empagliflozin | 396 | 620 | 91 | $348K |
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 356 | 473 | 80 | $391K |
| Metformin Hcl Generic | 356 | 1,043 | 123 | $2,687 |
| Glipizide Er Glipizide | 354 | 945 | 115 | $8,241 |
| Trijardy Xr Empaglifloz/Linaglip/Metformin | 310 | 497 | 64 | $286K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 298 | 761 | 130 | $28K |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 266 | 455 | 75 | $300K |
| Pioglitazone Hcl Generic | 243 | 618 | 70 | $3,443 |
| Trulicity Dulaglutide | 230 | 339 | 58 | $326K |
| Farxiga Dapagliflozin Propanediol | 224 | 389 | 54 | $208K |
| Atorvastatin Calcium Generic | 209 | 571 | 70 | $2,120 |
| Tresiba Flextouch U-200 Insulin Degludec | 188 | 326 | 60 | $209K |
Brand drugs: 4,975 claims; generic drugs: 3,395 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Timothy Daniel $14K ($14K in general payments such as food, travel and fees) from 23 companies. The largest payer was Abbott Laboratories with $11K.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 35 | $11K |
| Novo Nordisk Inc NVO | 14 | $345 |
| Sanofi-Aventis U.S. LLC SNY | 8 | $308 |
| Madrigal Pharmaceuticals MDGL | 5 | $266 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $265 |
| Corcept Therapeutics CORT | 10 | $207 |
| CeQur Corporation | 2 | $162 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $92.03 |
| Abiomed JNJ | 3 | $91.68 |
| Amgen Inc. AMGN | 4 | $80.2 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.